FDA.reportPublic FDA data

terlipressin 0.85 MG Injection [Terlivaz]

RxCUI
2612436
RxNorm name
terlipressin 0.85 MG Injection [Terlivaz]
Display name
terlipressin 0.85 MG Injection [Terlivaz]
Full name
terlipressin 0.85 MG Injection [Terlivaz]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:38:54

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
3a35b86c-f451-4fac-8499-43019e4da354Terlivaz 0.85 MG Injection [PSN] · terlipressin 0.85 MG Injection [Terlivaz] [SBD] · Terlivaz 0.85 MG Injection [SY]36These highlights do not include all the information needed to use TERLIVAZ ® safely and effectively. See full prescribing information for TERLIVAZ. TERLIVAZ (terlipressin) for injection, for intravenous use Initial U.S. Approval: 202220251111